OPTIMIZERx, Sudler & Hennessey Partner to Offer Solution to Pharmaceutical Industry's Number One Challenge: Keeping Patients on
30 September 2008 - 6:34PM
Marketwired
OPTIMIZERx Corp. (PINKSHEETS: OPRX), and S&H Digital, the
Interactive division of Sudler and Hennessey of WPP healthcare
communications agency (NASDAQ: WPPGY), announced today their plans
to enter into an exclusive relationship to create, market and
manage customized patient adherence programs for leading
prescription and healthcare brands through the launch of ADHERxE?.
ADHERxE? provides a turn-key platform to build powerful
compliance programs that allow brands to engage, monitor and
support patients each month to help them maintain their therapy. In
addition to providing access to educational support, ADHERxE?
programs allows patients to activate monthly co-pay coupons in
exchange for entering a branded Relationship Marketing ("RM")
program. An important component of the RM program is completion of
a survey to determine the patient's treatment status.
From there, patients are re-engaged through emails, follow-up
reminders and other programs based on their survey results to help
them better comply with their prescribed therapy. The program and
monthly offers are jointly designed, hosted and managed by
OPTIMIZERx and S&H Digital. Content and creative is developed
and managed by S&H Digital, leveraging the agency's expertise
in online pharmaceutical marketing and regulatory compliance.
Promotion of the program is integrated within OPTIMIZERx.com and
its vast affiliate network, while redemptions of monthly co-pay
coupons are accessible in a network of over 60,000 pharmacies.
"Our partnership with Sudler & Hennessey allows brands to
have one place to go to create powerful and engaging support
programs that truly help patients comply to their important chronic
therapies," stated David Harrell, CEO of OPTIMIZERx Corp.
"This is an exciting opportunity that fulfils a big healthcare
need of finding ways to increase patient compliance. We are excited
to partner on the launch of ADHERxE?, and integrate our creative
design services and healthcare experience within this powerful
platform. We can now offer brands a unique way to engage and
support patients each month and help improve patient outcomes,"
stated Robert Palmer, Managing Partner of S&H Digital.
About OPTIMIZERx Corporation:
OPTIMIZERx provides unique platforms to help patients better
afford and comply to their medicines and healthcare products, while
offering pharmaceutical and healthcare companies effective ways to
expand patient awareness, access and adherence to their brands. The
Company's web-based consumer information and patient support
website, www.OPTIMIZERx.com, and its permanent subscriber base,
continues to grow each month and is quickly becoming the preferred
way to access branded prescription savings and support programs.
Additionally, OPTIMIZERx has integrated and developed peripheral
offerings and capabilities, most obviously the newly launched
OFFERx? offer management system and ADHERxE? to allow more brands
to participate in promoting a new trial or co-pay program, as well
as sophisticated online behavioural re-targeting and database
marketing of brand-name pharmaceuticals, OTC medications, medical
devices, and healthcare services.
About S&H Digital:
S&H Digital is a full-service digital agency with
capabilities in account management and creative services; strategy
and research; Web development technology; search engine marketing
and online media; email and database marketing; reporting and
analytics; and staying ahead of the curve on emerging technologies.
Specializing in the health and wellness categories, with an
emphasis on pharmaceutical marketing, S&H Digital has deep
experience in Direct to Patient, Direct to Consumer, and
professional online marketing. As a member of the Sudler &
Hennessey global network, S&H Digital ensures a tightly
integrated strategic approach that supports the full spectrum of
commercial interests of the brand.
'SAFE HARBOR'
This press release contains forward-looking statements within
the definition of Section 27A of the Securities Act of 1933, as
amended and such section 21E of the Securities Act of 1934,
amended. These forward-looking statements should not be used to
make an investment decision. The words 'estimate,' 'possible' and
'seeking' and similar expressions identify forward-looking
statements, which speak only as to the date the statement was made.
The company undertakes no obligation to publicly update or revise
any forward-looking statements, whether because of new information,
future events, or otherwise. Forward-looking statements are
inherently subject to risks and uncertainties, some of which cannot
be predicted, or quantified. Future events and actual results could
differ materially from those set forth in, contemplated by, or
underlying the forward-looking statements. The risks and
uncertainties to which forward-looking statements are subject
include, but are not limited to, the effect of government
regulation, competition and other material risks.
Contact: Investor Relations First Capital Investors, Inc.
www.firstcapitalinvestors.com Email Contact 321-221-2910
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jul 2023 bis Jul 2024